Dumbrava, E. E., Shapiro, G. I., Parikh, A. R., Johnson, M. L., Tolcher, A. W., Thompson, J. A., El-Khoueiry, A. B., Vandross, A. L., Kummar, S., Shepard, D. R., LeDuke, K., Sheehan, L., Alland, L., Haque, A., Jalota, D., Fellous, M., Schram, A. M. (2026). Phase 1 Study of Rezatapopt, a p53 Reactivator, in
                    <i>TP53</i>
                    Y220C–Mutated Tumors. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2508820